Positioning/Sentiment: Open-interest Put/Call at 1.25 suggests more downside hedging / cautious-to-bearish positioning.
Flow: Volume Put/Call at 0.58 is more call-leaning on the day, but today’s total volume is low vs 30D average (~18%), so the bullishness is not strongly confirmed.
Volatility: 30D IV ~72.7 vs historical vol ~39.9 = options are pricing large moves; IV percentile ~47.9 (mid-range), not an extreme premium.
Takeaway: Mixed near-term flow, but overall stance remains defensive given elevated put open interest.
Technical Summary
Sell
9
Buy
3
Positive Catalysts
is reclaimed decisively.
Neutral/Negative Catalysts
Fundamentals are contracting (latest quarter revenue, net income, EPS all down YoY), keeping pressure on sentiment.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: $265.633M, down -10.48% YoY (topline contraction persists).
Net Income: $10.605M, down -69.84% YoY.
EPS: $0.23, down -67.14% YoY.
Margin: Gross margin 90.82%, up +1.92% YoY (cost/mix improving, but not offsetting revenue decline).
Overall: Profitability and growth trends are weakening despite strong gross margin—doesn’t support an aggressive buy-at-market approach right now.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent street stance: Neutral bias with price targets cut.
2025-11-10 (UBS): PT cut to $15 from $22, rating Neutral; cites topline weakness (network/unbranded SEO), expects easing into 2026; notes valuation/FCF yield may limit downside.
2025-11-06 (Goldman Sachs): PT cut to $27 from $32, rating Neutral.
Wall Street pros: strong free cash flow yield / valuation support; potential for investor interest once revenue growth returns (framed around 2026).
Wall Street cons: ongoing revenue pressure and reduced EBITDA outlook; visibility on re-acceleration remains the key overhang.
Trading behavior: Hedge funds Neutral; insiders Neutral; no recent Congress trading data available.
Wall Street analysts forecast ANGI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ANGI is 20.17 USD with a low forecast of 14 USD and a high forecast of 27 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
Wall Street analysts forecast ANGI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ANGI is 20.17 USD with a low forecast of 14 USD and a high forecast of 27 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
4 Hold
0 Sell
Moderate Buy
Current: 11.450
Low
14
Averages
20.17
High
27
Current: 11.450
Low
14
Averages
20.17
High
27
UBS
Neutral
downgrade
$22 -> $15
AI Analysis
2025-11-10
Reason
UBS
Price Target
$22 -> $15
AI Analysis
2025-11-10
downgrade
Neutral
Reason
UBS lowered the firm's price target on Angi Inc. to $15 from $22 and keeps a Neutral rating on the shares. Topline weakness stemmed from softer network and unbranded SEO channels, though these pressures should ease into 2026 as traffic mix improves, the analyst tells investors in a research note. Despite reduced EBITDA estimates for 2026-2027, Angi's valuation and strong free cash flow yield suggest limited downside, with investor interest likely to return once revenue growth turns positive in 2026, UBS says.
Goldman Sachs
Neutral
downgrade
$32 -> $27
2025-11-06
Reason
Goldman Sachs
Price Target
$32 -> $27
2025-11-06
downgrade
Neutral
Reason
Goldman Sachs lowered the firm's price target on Angi Inc. to $27 from $32 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ANGI
